Industry sponsored sessions
November 6, 2019, 08:00 - 12:00, room BOSTON 1-3
Industry Sponsored Workshop - ViiV Healthcare
IMPLEMENTATION SCIENCE BASICS:THE WHAT, WHO, WHY, AND HOW
Chair: Maggie Czarnogorski (USA)
|
Arrivals and coffee |
07:50 - 08:00 |
|
Welcome |
08:00 - 08:15 |
|
Implementation Science: The What, Who and Why Cassidy Gutner (USA) |
08:15 - 08:45 |
|
Q&A Panel / All |
08:45 - 09:15 |
|
Implementation Science: The How Cassidy Gutner (USA) |
09:15 - 10:00 |
|
Q&A Panel / All |
10:00 - 10:30 |
|
Coffee break |
10:30 - 10:45 |
|
Interactive Workshop |
10:45 - 11:55 |
|
Summary and Close Maggie Czarnogorski (USA) |
11:55 - 12:00 |
November 6, 2019, 13:15 - 14:45, room SYDNEY
Industry Sponsored Session - Janssen Pharmaceutica
“A clinical journey through the 90 90 90 90”
Chairs: Alan Winston (United Kingdom), Karine Lacombe (France)
|
Welcome |
13:15- 13:17 |
|
Clinical case and expert insights: First 90: Testing |
13:17 - 13:32 |
|
Clinical case and expert insights: Second 90: Retention in care Cristiana Oprea (Romania) |
13:32 - 13:47 |
|
Clinical case and expert insights: Third 90: Antiretroviral therapy Anton Pozniak (United Kingdom) |
13:47 - 14:02 |
|
Clinical case and expert insights: Fourth 90: Quality of life Antonella Cingolani (Italy) |
14:02 - 14:17 |
|
Panel discussion All faculty |
14:17 - 14:42 |
|
Conclusions |
14:42 - 14:45 |
November 6, 2019, 15:00 - 16:30, room SAN FRANCISCO
Industry Sponsored Session - Gilead
Together We Can; Working in partnership to achieve common goals
|
Welcome |
15:00 - 15:05 |
|
Collaborative successes in moving the needle towards 90-90-90; |
15:05 - 15:35 |
|
Challenging the status quo – the future of HIV care |
15:35 - 15:45 |
|
Looking beyond 90-90-90: Meeting the needs of the 10-10-10 |
15:45 - 16:25 |
|
Symposium close |
16:25 - 16:30 |
November 7, 2019, 07:30 - 08:30, room SAN FRANCISCO
Industry Sponsored Session - Medscape
(supported by an independent educational grant from ViiV Healthcare)
The Pathway to Successful Aging for PLWH: Listening to the Patient and Learning from Geriatrics
Chair: Giovanni Guaraldi (Italy)
|
Welcome and Introductions |
07:30 - 07:37 |
|
Patient Case Presentation Giovanni Guaraldi (Italy) |
07:37 - 07:42 |
|
Prevention of Comorbidities |
07:42 - 07:52 |
|
Management of Comorbidities Julian Falutz (Canada) |
07:52- 08:02 |
|
Principles and Practices for the Care of Geriatric PLWH Giovanni Guaraldi (Italy), Julian Falutz (Canada), Philip E. Tarr (Switzerland) and patient (TBC) |
08:05 - 08:20 |
|
Conclusion, Post-Test, Q&A Giovanni Guaraldi (Italy) |
08:20 - 08:30 |
November 7, 12:15 - 13:30, room SAN FRANCISCO
Industry Sponsored Session - ViiV Healthcare
A tale of two drugs: evidence into practice
(This symposium is for healthcare professionals)
Chairs: Jean van Wyk (United Kingdom)
|
Welcome |
12:15 - 12:20 |
|
Challenging the narrative: does a two-drug combination have the strength of three? |
12:20 - 12:40 |
|
Extending the narrative: two drugs in clinical practice Carlo Perno (Italy), Juan Berenguer (Spain) |
12:40 - 13:20 |
|
Summary, discussion and close |
13:20 - 13:30 |
November 7, 12:15 - 13:45, room SYDNEY
Industry sponsored session - MSD
“No more to learn in HIV”? Don’t be so sure…
Chairs: Laura Waters (United Kingdom)
|
Opening/Welcome |
12:15 - 12:20 |
|
“Hot topics in HIV care” |
12:20 - 12:40 |
|
Role of NNRTIs in HIV Care |
12:40 - 13:00 |
|
“Women & HIV: An Unbalanced Scale” Karine Lacombe (France) |
13:00 - 13:20 |
|
Patient Case Round table |
13:20- 13:40 |
|
Q&A/Closing |
13:40 - 13:45 |
November 7, 17:45 - 18:45, room SYDNEY
Industry Sponsored Session - Roche
Diagnostics of the unknown or Keeping up with emerging infections and biomedical HIV prevention
|
Welcome and Introduction |
17:45 - 17:50 |
|
Causal or Guilt by Association? Bacterial STI’s in the era of Biomedical HIV prevention |
17:50 - 18:10 |
|
Emerging arboviruses and diagnostic challenges |
18:10 - 18:30 |
|
Q&A |
18:30 - 18:45 |
November 7, 17:45 - 19:15, room SAMARKAND-OSAKA
Industry Sponsored Session - Theratechnologies Inc.
Beating Resistance: Finding new treatment paths for difficult-to-treat HIV patients
Chair: Carlo Federico Perno (Italy)
|
Icebreaker: Interactive Discussion |
17:45 - 17:50 |
|
Introduction: Managing Difficult-to-Treat HIV Patients |
17:50 - 18:00 |
|
Epidemiology of Difficult-to-Treat HIV Patients |
18:00 - 18:10 |
|
Case Presentation and Discussion |
18:10 - 18:20 |
|
Q&A |
18:20 - 18:25 |
|
Virologist Approach to Building an Optimized Regimen for Difficult-to-Treat HIV Patients Carlo Federico Perno (Italy) |
18:25 - 18:40 |
|
Interactive Discussion Carlo Federico Perno (Italy) |
18:40 - 18:45 |
|
Clinician Approach to Building an Optimized Regimen for Difficult-to-Treat HIV Patients Graeme J. Moyle (United Kingdom) |
18:45 - 18:55 |
|
Case Presentation and Discussion Graeme J. Moyle (United Kingdom) |
18:55 - 19:05 |
|
Conclusion and Q&A Carlo Federico Perno (Italy) |
19:05 - 19:15 |
November 8, 2019, 12:15 - 13:45, Room SAN FRANCISCO
Industry Sponsored Session - Gilead
Hearing Individual Voices
Chair: Matthias Cavassini (Switzerland)
|
Welcome and introduction |
12:15 - 12:20 |
|
Exploring patient cases: theatrical performances and panel discussion |
12:20 - 13:30 |
|
Santiago’s story: Becoming the informed patient |
12:20 - 12:55 |
|
Janet’s journey: From diagnosis to long-term management |
12:55 - 13:30 |
|
Q&A with faculty panel |
13:30 - 13:40 |
|
Summary & close Matthias Cavassini (Switzerland) |
13:40 - 13:45 |
November 8, 2019, 16:15 - 17:45, Room SAN FRANCISCO
Industry Sponsored Session - Clinical Care Options, LLC
(supported by an independent educational grant from ViiV Healthcare)
Broader Horizons: Incorporating ART Advances Into Patient Care
Chair: Jean-Michel Molina (France)
|
Welcome and Introduction |
16:15 - 16:20 |
|
Reviewing Recent Advances in ART |
16:20 - 16:40 |
|
Expert Guidance on Selecting First-line Therapy and Switch Strategies: Case-Based Discussion |
16:40 - 17:25 |
|
Question and Answer Session |
17:25 - 17:40 |
|
Conclusions and Closing Thoughts |
17:40 - 17:45 |
